Advertisement

Onchocerciasis and Lymphatic Filariasis

  • Achim Hoerauf
  • Anna Albers
Chapter

Abstract

Infections with parasitic worms are widespread in tropical and sub-tropical areas of the world. In particular, infections with filarial nematodes occur in hot climate zones including lymphatic filariasis, onchocerciasis and loiasis; Mansonella species which occur in parts of Central Africa and Central and South America usually cause mild clinical symptoms. All filarial infections are transmitted by flying insects; humans are the only reservoir. Throughout the hot climate zones in Africa, approximately 130–150 million people are affected; the prevalence has clear association with poverty. Despite ongoing control programmes, lymphatic filariasis and onchocerciasis have been included in the list of neglected tropical diseases (NTD) by the WHO.

References

  1. 1.
    Develoux M, Hennequin C, Le Loup G, et al. Imported filariasis in Europe: a series of 31 cases from Metropolitan France. Eur J Intern Med. 2017;37:e37–9.  https://doi.org/10.1016/j.ejim.2016.09.021.
  2. 2.
    Antinori S, Parravicini C, Galimberti L, et al. Is imported onchocerciasis a truly rare entity? Case report and review of the literature. Travel Med Infect Dis. 2017;16:11–7.  https://doi.org/10.1016/j.tmaid.2017.02.006. pii: S1477-8939(17)30012-1.CrossRefPubMedGoogle Scholar
  3. 3.
    Belhassen-García M, Pardo-Lledías J, Pérez del Villar L, et al. Relevance of eosinophilia and hyper-IgE in immigrant children. Medicine (Baltimore). 2014;93:e43.  https://doi.org/10.1097/MD.0000000000000043.CrossRefGoogle Scholar
  4. 4.
    Baum S, Greenberger S, Pavlotsky F, et al. Late-onset onchocercal skin disease among Ethiopian immigrants. Br J Dermatol. 2014;171:1078–83.CrossRefPubMedGoogle Scholar
  5. 5.
    Coffeng LE, Stolk WA, Zouré HG, et al. African programme for onchocerciasis control 1995-2015: updated health impact estimates based on new disability weights. PLoS Negl Trop Dis. 2014;8:e2759.  https://doi.org/10.1371/journal.pntd.0002759.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    WHO weekly epidemiological record. 2016;91:501–16.Google Scholar
  7. 7.
    Adjobimey T, Hoerauf A. Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation. Ann Trop Med Parasitol. 2010;104:455–64.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Murdoch ME, Hay RJ, Mackenzie CD, et al. A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol. 1993;129:260–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Korten S, Wildenburg G, Darge K, et al. Mast cells in onchocercomas from patients with hyperreactive onchocerciasis (sowda). Acta Trop. 1998;70:217–31.CrossRefPubMedGoogle Scholar
  10. 10.
    Klarmann-Schulz U, Batsa-Debrah L, Osei-Mensah J, Dubben B, Fischer K, Mubarik Y, Ricchiuto A, Fimmers R, Weil GJ, Kazura JW, King CL, Debrah AY, Hoerauf A. The addition of albendazole to ivermectin does not reduce female worm fertility in onchocerciasis. Am J Trop Med Hygiene. 2017;97:166.CrossRefGoogle Scholar
  11. 11.
    Debrah AY, Specht S, Klarmann-Schulz U, et al. Doxycycline leads to sterility and enhanced killing of female Onchocerca volvulus worms in an area with persistent microfilaridermia after repeated ivermectin treatment: a randomized, placebo-controlled, double-blind trial. Clin Infect Dis. 2015;61:517–26.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Arndts K, Deininger S, Specht S, et al. Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti. PLoS Negl Trop Dis. 2012;6:e1611.  https://doi.org/10.1371/journal.pntd.0001611.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Mand S, Marfo-Debrekyei Y, Dittrich M, et al. Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis. Filaria J. 2003;2:3.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Debrah AY, Mand S, Specht S, et al. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog. 2006;2:e92.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Pion SD, Chesnais CB, Weil GJ, et al. Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo. Lancet Infect Dis. 2017;17:763–9.  https://doi.org/10.1016/S1473-3099(17)30175-5. pii: S1473-3099(17)30175-5.CrossRefPubMedGoogle Scholar
  16. 16.
    Debrah AY, Mand S, Marfo-Debrekyei Y, et al. Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti. Trop Med Int Health. 2007;12:1433–41.CrossRefPubMedGoogle Scholar
  17. 17.
    Mand S, Debrah AY, Klarmann U, et al. Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial. Clin Infect Dis. 2012;55:621–30.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Thomsen EK, Sanuku N, Baea M, et al. Efficacy, safety, and pharmacokinetics of coadministered diethylcarbamazine, albendazole, and ivermectin for treatment of bancroftian filariasis. Clin Infect Dis. 2016;62:334–41.CrossRefPubMedGoogle Scholar
  19. 19.
    Aljayyoussi G, Tyrer HE, Ford L, et al. Short-course, high-dose rifampicin achieves wolbachia depletion predictive of curative outcomes in preclinical models of lymphatic filariasis and onchocerciasis. Sci Rep. 2017;7:210.  https://doi.org/10.1038/s41598-017-00322-5.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Institut für Med. Mikrobiologie, Immunologie und Parasitologie, Deutsches Zentrum für InfektionsforschungUniversitätsklinikum BonnBonnGermany

Personalised recommendations